Hydroxychloroquine is being used for compassionate treatment of COVID-19 in the United States.

The U.S. Food and Drug Administration (FDA) has issued an Emergency Use Authorization (EUA) to permit the emergency use of hydroxychloroquine.

Although there are no U.S. Food and Drug Administration (FDA) approved drugs to treat COVID-19 yet, hydroxychloroquine or chloroquine has been administered to COVID-19 patients in the U.S. for alleviating symptoms. The fact sheet released by the FDA says that if it is used on patients, they must do it with caution and monitor their electrocardiogram during treatment. It also says that information on dosage would be updated based on clinical trials.

The National Institutes of Health (NIH) COVID-19 treatment guidelines state that If chloroquine or hydroxychloroquine is used, clinicians should monitor the patient for adverse effects.

Reference links

U.S. Food and Drug Administration

neutral

COVID-19 Treatment Guidelines

neutral

World Health Organization

neutral

Have a question or correction on one of our fact-checks?

If you think a claim has been misjudged or requires correction, please send us evidence to support your error claim. We will revisit our evidence and verdict and conduct additional research to verify new information.

Fact Check of the Day

false

The BBC censored the crowd booing Boris Johnson at the Queen’s Platinum Jubilee celebrations.